18F-Florbetapir PET in Primary Cerebral Amyloidoma

Frederik Soffers1, Sarah Ceyssens1, Wendi Buffet2

  • 1From the Department of Nuclear Medicine, University Hospital of Antwerp.

Insights

Primary cerebral amyloidoma, a rare focal amyloid deposition, can mimic tumors. F-florbetapir PET/CT aids in diagnosing this condition, especially when biopsy is not possible.

Area of Science:

  • Neuropathology
  • Neuroradiology
  • Nuclear Medicine

Background:

  • Amyloid deposition is linked to Alzheimer disease and cerebral amyloid angiopathy.
  • Primary cerebral amyloidoma is a rare focal deposition that can present as a tumor-like lesion.
  • Misdiagnosis as a neoplasm is a concern due to similar imaging characteristics.

Observation:

  • A 54-year-old woman presented with a periventricular white matter mass on MRI.
  • The mass showed T2-hyperintensity and moderate contrast enhancement.
  • Pathological investigation confirmed AL (lambda) amyloidoma.

Findings:

  • F-florbetapir PET/CT was utilized for diagnostic support and patient follow-up.
  • The imaging findings were consistent with amyloid deposition.
  • This case demonstrates the utility of F-florbetapir PET/CT in identifying amyloidoma.

Implications:

  • F-florbetapir PET/CT may be a valuable tool in the diagnostic workup of suspected cerebral amyloidoma.
  • This imaging modality is particularly useful in cases where biopsy is not feasible.
  • Improved diagnostic accuracy can lead to appropriate management and reduce unnecessary interventions for suspected neoplasms.